A Study on Oriental Medicine Diagnostic Application through Analysis of Heart Rate Variability in Polycystic Ovary Syndrome Females
![]() |
Lee, Mi-Joo
(KangNam Kyung-Hee Oriental Hospital)
Hwang, Deok-Sang (KangNam Kyung-Hee Oriental Hospital) Lee, Jin-Moo (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) Lee, Chang-Hoon (KangNam Kyung-Hee Oriental Hospital) Cho, Jung-Hoon (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) Jang, Jun-Bock (Dept. of Oriental Gynecology, College of Oriental Medicine, Kyung-Hee University) Lee, Khung-Sub (KangNam Kyung-Hee Oriental Hospital) |
1 | Boulman N et al . Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. J CLin Endothelial Metab. 2004;89:2160-5. DOI ScienceOn |
2 | 張鳳嬋, 薛耀. 中醫藥治療多囊性卵巢綜合症方法初探. 新中醫. 1996;1:14-6. |
3 | Huikuri et al. Sex related difference in autonomic modulation of heart rate in middle-aged subjects. Circulation. 1996;94:122-5. DOI ScienceOn |
4 | Holly R. Impact of acute mental stress on sympathetic nerve activity and regional blood flow in advanced heart failure. Circulation. 1997;96:1835-42. DOI ScienceOn |
5 | Paradisi G et al. Polycystic ovarysyndrome in associated with endothelial dysfunction. Circulation. 2001;103:1410-5. DOI ScienceOn |
6 | 박휘라 등. 한국인 다낭난소증후군 환자의 임상특징. 대한내과학회지. 2007; 73(2):169-74. |
7 | Prelevic GM et al. Cardiac flow velocity in women with polycystic ovary syndrome. Clin Endocrinol. 1995; 43:677-81. DOI |
8 | Yarali H et al. Diastolic dysfunction and increased serum homocystein concentrations may contrubute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertil Steril. 2001;76:511-6. DOI ScienceOn |
9 | Yildiz BO et al. Global fibrinolytic capacity in decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab. 2002; 87:3871-5. DOI ScienceOn |
10 | Kleiger RE, Stin PK, Bigger JT. Heart rate variablility:Measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10;88-101. DOI ScienceOn |
11 | Lergo RS. Change in glucose intlerance over time in woman with polysystic syndorome: a controlled study. J Clin Endocrinol Metab. 2005;90:3236-42. DOI ScienceOn |
12 | Christian RC et al. Precalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88: 2562-8. DOI ScienceOn |
13 | Lakhani K et al. Intima-medial thickness of elastic and musculra arteries of young women with polycystic ovaries. Atherosclerosis. 2004;175:353-9. DOI ScienceOn |
14 | JE Nestler. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Sem Reprod Endocrinol. 1997;15:111-22. DOI ScienceOn |
15 | 조성연 등. 내관 애구가 정신적 스트레스를 가한 성인의 심박변이도에 미치는 영향. 대한침구학회지. 2010; 27(4):51-8. 과학기술학회마을 |
16 | 陳貴延, 楊思樹. 實用中西醫結合診斷治療學, 北京中國醫藥科指出版社. 1991: 1004-9. |
17 | Task Force of European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement physiologic interpretation and clinical use. Circulation. 1996; 93:1043-65. DOI ScienceOn |
18 | Fei L et al. Short and long term assessment of heart rate variability for risk stratification after acute myocardial infarction. Am J cardiol. 1996;77:681-4. DOI ScienceOn |
19 | Kelly CJ et al. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:742-6. DOI ScienceOn |
20 | 성연아. 다낭난소증후군과 인슐린저항성. KOREAN DIABETES. 2008; 32:1-6. DOI ScienceOn |
21 | Aylin Yildirir et al. Heart rate variability in young women with polycystic ovary syndrome. Annals of Noninvasive Electrocardiology. 2006;11(4):306-12. DOI ScienceOn |
22 | Wijeyaratne CN et al. Clinical manifestarions and insulin resistance in polycystic ovary syndrome among asians and caucasians: Is there a difference? Clin Endocrinol. 2002;57:343-50. DOI ScienceOn |
23 | 변은경 등. 서울지역 여자대학생에서 다낭성난소증후군의 유병률. 대한내분비학회지. 2005;20(6):120-6. |
24 | 이용제 등. 대사증후군과 심박도의 변이와의 관계. 가정의학회지. 2002; 23(12):1432-9. |
25 | Evrengul H et al. The relationship between heart rate recovery and heart rate variabiliry in coronary artery disease. Electrocardiol. 2006;11(2): 154-62. |
26 | 오상훈, 황민철, 임재중. HRV에 의한 시각감성의 구분에 대한 연구. 대한인간공학회. 1997;2:473-6. |
27 | Legro RS. Polycystic ovary syndrome: the new millenium. Mol Cell Endocrinol. 2002;186:882-92. |
28 |
O'Meara NM et al . Defects in |
29 | Carmina E et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119:356. e1-e6. DOI |
30 | Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiacactheterization. Ann Interm Med. 1997;126:32-5. DOI ScienceOn |
31 | Azziz R et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome. J Clin Endothelial Metab. 2001;86:1626-32. DOI ScienceOn |
32 | 민응기. 다낭성 난소 증후군. Korean journal of Obstetrics and Gynecology. 2008;51(8):805-19. |
33 | The Rotterdam ESHRE/ASRM-sponsored PCOS consesus workshop group. Revised 2003 consensus on diagnostic criteria and long health risks related to polycystic ovary syndrome. Hum Reprod. 2004; 19:41-7. DOI ScienceOn |
34 | Legro RS, Kenselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111:607-13. DOI ScienceOn |
![]() |